Abstract
Biomarkers can be used to characterize disease status or predict disease behavior. Cancer biomarkers have typically relied on assays of blood or tissue; however, molecular imaging has a promising and complementary role as a cancer biomarker. This 'Focus on Molecular Imaging' article reviews the current role of biomarkers to direct cancer clinical trials and clinical practice, along with current and future cancer biomarker applications of molecular imaging. © 2014 SNMMI; all rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Mankoff, D. A., Pryma, D. A., & Clark, A. S. (2014). Molecular imaging biomarkers for oncology clinical trials. Journal of Nuclear Medicine, 55(4), 525–528. https://doi.org/10.2967/jnumed.113.126128
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
